<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on VENTECH from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated VENTECH news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 05:30:04 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=VENTECH" rel="self" type="application/rss+xml" />

	
<item><title>EyeGate Pharma secures funding to continue developing potential dry eye treatment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3891299&amp;HITNO=0&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3891299&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2459656687%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3891299&amp;HITNO=0&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3891299&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2459656687%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>OSN Super Site:</description></item>
<item><title>EyeGate Pharma raises $22.6m for dry eye treatment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3886064&amp;HITNO=1&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3886064&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2457619739%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3886064&amp;HITNO=1&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3886064&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2457619739%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>AltAssets.net:</description></item>
<item><title>EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndr</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3883599&amp;HITNO=2&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3883599&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2455959309%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3883599&amp;HITNO=2&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3883599&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2455959309%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MediLexicon:</description></item>
<item><title>Eyegate Pharma has $23M round in focus</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3880462&amp;HITNO=3&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3880462&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453383701%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3880462&amp;HITNO=3&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3880462&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453383701%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Charlotte Business Journal:</description></item>
<item><title>EyeGate Pharma Raises $22.6 Million</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3877696&amp;HITNO=4&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3877696&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452021995%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3877696&amp;HITNO=4&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3877696&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452021995%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Private Equity HUB:</description></item>
<item><title>Covagen extends financing round and adds Edmond de Rothschild Investment Partners (EdRIP) to investor syndicat</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3877633&amp;HITNO=5&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3877633&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451998955%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3877633&amp;HITNO=5&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3877633&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451998955%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndr</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3880091&amp;HITNO=6&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3880091&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453171780%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3880091&amp;HITNO=6&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3880091&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453171780%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Healthcare Sales &amp; Marketing Network:</description></item>
<item><title>EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndr</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3880052&amp;HITNO=7&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3880052&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453149998%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3880052&amp;HITNO=7&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3880052&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453149998%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharmacy Choice:</description></item>
<item><title>Eyegate Pharma has $23M round in focus</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3879617&amp;HITNO=8&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3879617&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452941680%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3879617&amp;HITNO=8&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3879617&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452941680%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Houston Business Journal:</description></item>
<item><title>Eyegate Pharma has $23M round in focus</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3879532&amp;HITNO=9&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3879532&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452902099%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3879532&amp;HITNO=9&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3879532&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452902099%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Journal of Jacksonville:</description></item>
<item><title>::: EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye S</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3879468&amp;HITNO=10&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3879468&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452854409%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3879468&amp;HITNO=10&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3879468&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452854409%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Biotech Intelligence:</description></item>
<item><title>EyeGate Pharma Secures $</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3878058&amp;HITNO=11&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3878058&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452149796%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3878058&amp;HITNO=11&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3878058&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2452149796%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>BioSpace:</description></item>
<item><title>EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndr</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3876619&amp;HITNO=12&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3876619&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451622775%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3876619&amp;HITNO=12&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3876619&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451622775%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndr</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3876587&amp;HITNO=13&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3876587&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451607048%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3876587&amp;HITNO=13&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3876587&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451607048%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndr</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3876509&amp;HITNO=14&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3876509&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451547377%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3876509&amp;HITNO=14&amp;MSIZE=19&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=VENTECH&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3876509&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2451547377%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Marketwire via Yahoo!:</description></item>
</channel></rss>